论文信息 - Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial. - 字舞流文

Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial.

J. Bahary | N. Carrier | L. Souhami | M. Duclos | André-Guy Martin | A. Nabid | B. Bahoric | R. Archambault | F. Vincent | R. Bettahar | M. Garant | C. Lemaire | S. Vass